GT Biopharma GTBP
NASDAQ GTBP
$6.98 +0.18 (+2.65%)
As of: Sep 30, 2026 · 10:18 AM EDT

GT Biopharma (GTBP) FCF Margin (2010 - 2015)

Updated

GT Biopharma (GTBP) recorded FCF Margin of -17251.85% in FY2015, down 14374.80 percentage points from -2877.05% in FY2014.

Analysis

GT Biopharma (GTBP) FCF Margin (2010 - 2015) Analysis & Trends

Starting with FY2010, GT Biopharma's FCF Margin history includes 5 years.

  • Annual FCF Margin has a five-year change of -3297.31 percentage points (FY2010 to FY2015).
  • The FY2015 figure is the lowest annual FCF Margin in data going back to FY2010.
  • Per Business Quant data, GTBP's FCF Margin was -2877.05% in FY2014, -289.18% in FY2012 (+3414.66 pp) and -3703.85% in FY2011 (+10250.70 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.82%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 18.33%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 26.96%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 43.05%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 34.72%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.70%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 30.39%
10 GT Biopharma 9.57 Mn 9.57 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 -6,465.00%
Mar 31, 2015 -25,528.57%
Mar 31, 2013 -156.82%
Dec 31, 2012 -97.72%
Sep 30, 2012 -231.67%
Jun 30, 2012 -30,300.00%
Mar 31, 2012 -19,200.00%
Dec 31, 2011 -10,800.00%
Sep 30, 2011 -4,950.00%
Jun 30, 2011 -39,300.00%
Mar 31, 2011 -735.00%
Dec 31, 2010 -3,427.27%
API Access

GT Biopharma FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=GTBP&period=max&api_key=YOUR_API_KEY